Skip to main content

Butrans News

Related terms: Butrans Patch

Hospital Addiction Consultation Service Aids Opioid Use Disorder

WEDNESDAY, April 16, 2025 – A hospital-based addiction consultation service can improve receipt of evidence-based treatment for people with opioid use disorder (OUD), according to a study published...

Evidence Supports Continuing Buprenorphine for Acute Pain in Those With Opioid Use Disorder

MONDAY, March 31, 2025 – For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, but overall evidence for pain outcomes in these...

2017 to 2022 Saw Rise in ED Orders for Buprenorphine for Opioid Use Disorder

THURSDAY, Feb. 27, 2025 – Emergency clinicians in California increased prescription of buprenorphine for opioid use disorder (OUD) from 2017 to 2022, according to a study published online Feb. 19 in...

Mindfulness-Based Groups Tied to Significant Reduction in Opioid Craving

WEDNESDAY, Jan. 29, 2025 – For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery support group for opioid use, substance use, and...

2020 to 2023 Saw Increase in Buprenorphine Dispensing for Teens

THURSDAY, Dec. 26, 2024 – Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, according to a research letter published online Dec. 23 in the...

Methadone Tied to Lower Risk for Discontinuation Versus Buprenorphine/Naloxone

FRIDAY, Oct. 18, 2024 – Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared with buprenorphine/naloxone, according to a study...

Higher Buprenorphine Doses Reduce Acute Care for Opioid Use Disorder

WEDNESDAY, Oct. 2, 2024 – Higher doses of buprenorphine for patients with opioid use disorder (OUD) are associated with lower acute care utilization, according to a study published online Sept. 25...

Inmates in Many U.S. Jails Have No Access to Meds That Fight Opioid Addiction

TUESDAY, Sept. 24, 2024 – Opioid use disorder can be a contributing factor to Americans landing in the nation's prisons and jails, but those inmates typically have no access to medications that...

Socially, Economically Disadvantaged Communities Lack Access to Buprenorphine

FRIDAY, Aug. 23, 2024 – Restricted buprenorphine dispensing was most pronounced in socially and economically disadvantaged communities, according to a study published in the September issue of Drug ...

More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder

FRIDAY, July 12, 2024 – Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28...

Most Americans Don't Know That Family Doctors Can Prescribe Anti-Opioid Meds

TUESDAY, July 2, 2024 – Most people addicted to opioids and their loved ones are unaware that their primary care doctor can prescribe a medication to treat the disorder, a new nationwide survey...

Only 1 in 4 People Who Need Meds to Fight Opioid Addiction Get Them

THURSDAY, June 27, 2024 – Just 25% of people battling opioid use disorder are getting medications aimed at helping them quit and potentially avoid an overdose, new data shows. Boosting access to...

Most Outpatient Mental Health Clinics Don't Offer Opioid Addiction Meds

WEDNESDAY, June 19, 2024 – Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with...

Elimination of Buprenorphine Waiver Had Moderate Effect

MONDAY, May 6, 2024 – Elimination of the buprenorphine waiver increased the number of prescribers, but only modestly increased the number of patients in whom buprenorphine treatment was initiated,...

FDA Medwatch Alert: FDA Warns About Dental Problems with Buprenorphine Medicines Dissolved in the Mouth to Treat Opioid Use Disorder and Pain

What safety concern is FDA announcing? The U.S. Food and Drug Administration (FDA) is warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Chronic Pain, Pain

Butrans patient information at Drugs.com